ContractShared Care Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020SHARED CARE AGREEMENT Name of medicine Atomoxetine non-stimulant single use not in combination Indication For Children (aged 6 years and over) and Adolescents withAttention Deficit Hyperactivity Disorder (ADHD) Version: 1 Approval date: August 2019 Review date: August 2021